| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.05e-07 | 15 | 61 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 2.35e-05 | 112 | 61 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.90e-04 | 560 | 61 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 3.11e-04 | 566 | 61 | 8 | GO:0001216 | |
| GeneOntologyBiologicalProcess | female meiosis II | 1.03e-09 | 6 | 61 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.03e-09 | 6 | 61 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.03e-09 | 6 | 61 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 3.07e-07 | 151 | 61 | 7 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 9.86e-07 | 26 | 61 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.56e-06 | 29 | 61 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.05e-06 | 31 | 61 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | embryo development | HOXA5 HOXB5 HOXB8 GTF2I TENM4 USP9X LPA ROR2 SEC24B GATA3 TSHZ1 DLX3 CUBN FOXA1 RYR2 CDON | 2.87e-06 | 1437 | 61 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 4.25e-06 | 37 | 61 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | developmental maturation | 5.37e-06 | 439 | 61 | 9 | GO:0021700 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 5.87e-06 | 87 | 61 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 7.32e-06 | 91 | 61 | 5 | GO:0006446 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | HOXA5 HOXB5 FASN SLC9A4 KRT17 PTPRO NFE2L1 ESR1 SEC24B GATA3 DLX3 FOXA1 | 7.61e-06 | 870 | 61 | 12 | GO:0030855 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 8.72e-06 | 351 | 61 | 8 | GO:0048562 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 8.92e-06 | 164 | 61 | 6 | GO:0002065 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 9.42e-06 | 45 | 61 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 1.12e-05 | 47 | 61 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 1.17e-05 | 172 | 61 | 6 | GO:0051783 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.22e-05 | 101 | 61 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | cell maturation | 1.35e-05 | 267 | 61 | 7 | GO:0048469 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.69e-05 | 52 | 61 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.29e-05 | 115 | 61 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.76e-05 | 561 | 61 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 4.19e-05 | 713 | 61 | 10 | GO:0048598 | |
| GeneOntologyBiologicalProcess | translational initiation | 4.44e-05 | 132 | 61 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 7.19e-05 | 75 | 61 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | epithelium development | HOXA5 HOXB5 FASN SLC9A4 KRT17 PTPRO NFE2L1 ESR1 ROR2 SEC24B GATA3 DLX3 FOXA1 RYR2 | 7.64e-05 | 1469 | 61 | 14 | GO:0060429 |
| GeneOntologyBiologicalProcess | regionalization | 7.87e-05 | 478 | 61 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 7.97e-05 | 77 | 61 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 8.14e-05 | 354 | 61 | 7 | GO:0071695 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 8.88e-05 | 247 | 61 | 6 | GO:0009952 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 9.70e-05 | 251 | 61 | 6 | GO:2000241 | |
| GeneOntologyBiologicalProcess | regulation of translation | 9.89e-05 | 494 | 61 | 8 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 1.02e-04 | 82 | 61 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 1.13e-04 | 373 | 61 | 7 | GO:0006402 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.34e-04 | 88 | 61 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | mammary gland epithelial cell proliferation | 1.38e-04 | 34 | 61 | 3 | GO:0033598 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 1.41e-04 | 387 | 61 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.52e-04 | 526 | 61 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 1.53e-04 | 91 | 61 | 4 | GO:0002067 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 1.60e-04 | 395 | 61 | 7 | GO:0050803 | |
| GeneOntologyBiologicalProcess | oocyte development | 2.11e-04 | 99 | 61 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 2.27e-04 | 418 | 61 | 7 | GO:0009895 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 2.46e-04 | 103 | 61 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 2.77e-04 | 432 | 61 | 7 | GO:0006401 | |
| GeneOntologyBiologicalProcess | neuron development | RELN ARID1B TENM4 PTPRD MYO5B PTPRO USP9X ROR2 SEC24B GATA3 SECISBP2 TMEM30A ATP1B2 | 2.89e-04 | 1463 | 61 | 13 | GO:0048666 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HOXA5 HOXB5 HOXB8 ESR1 ROR2 SEC24B GATA3 TSHZ1 DLX3 FOXA1 RYR2 CDON | 2.93e-04 | 1269 | 61 | 12 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 2.99e-04 | 309 | 61 | 6 | GO:0061013 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 2.99e-04 | 906 | 61 | 10 | GO:0043009 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.41e-04 | 46 | 61 | 3 | GO:0000184 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 3.65e-04 | 929 | 61 | 10 | GO:0009792 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 4.13e-04 | 118 | 61 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 4.23e-04 | 612 | 61 | 8 | GO:0010975 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 4.26e-04 | 464 | 61 | 7 | GO:0141188 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 4.32e-04 | 614 | 61 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 4.56e-04 | 619 | 61 | 8 | GO:0002009 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | HOXA5 RELN ARID1B TENM4 PTPRD MYO5B ROR2 EIF4G1 GATA3 FOXA1 CDON | 4.61e-04 | 1141 | 61 | 11 | GO:0045597 |
| GeneOntologyBiologicalProcess | cell fate commitment | 4.82e-04 | 338 | 61 | 6 | GO:0045165 | |
| GeneOntologyBiologicalProcess | female gamete generation | 5.14e-04 | 223 | 61 | 5 | GO:0007292 | |
| GeneOntologyBiologicalProcess | prostate glandular acinus development | 5.57e-04 | 12 | 61 | 2 | GO:0060525 | |
| GeneOntologyBiologicalProcess | mesenchymal-epithelial cell signaling | 5.57e-04 | 12 | 61 | 2 | GO:0060638 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | RELN PTPRD MYO5B DAZ4 ROR2 EIF4G1 TMEM30A DAZ1 EPS8L1 DAZ3 DAZ2 ATP1B2 | 5.70e-04 | 1366 | 61 | 12 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 6.18e-04 | 494 | 61 | 7 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.65e-04 | 14 | 61 | 2 | GO:2000622 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 8.05e-04 | 846 | 61 | 9 | GO:0120035 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 8.07e-04 | 141 | 61 | 4 | GO:0060996 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 8.45e-04 | 249 | 61 | 5 | GO:0010976 | |
| GeneOntologyBiologicalProcess | positive regulation of protein exit from endoplasmic reticulum | 8.81e-04 | 15 | 61 | 2 | GO:0070863 | |
| GeneOntologyBiologicalProcess | synapse organization | 8.85e-04 | 685 | 61 | 8 | GO:0050808 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 9.26e-04 | 863 | 61 | 9 | GO:0031344 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 1.03e-03 | 67 | 61 | 3 | GO:0050775 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.12e-03 | 154 | 61 | 4 | GO:0042471 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 1.12e-03 | 69 | 61 | 3 | GO:0010770 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell development | 1.12e-03 | 69 | 61 | 3 | GO:0002066 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.12e-03 | 69 | 61 | 3 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.17e-03 | 70 | 61 | 3 | GO:1900047 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HOXA5 RELN PTPN14 GTF2I TENM4 LPA ROR2 SEC24B GATA3 ERVK-19 FOXA1 CDON | 1.17e-03 | 1483 | 61 | 12 | GO:0048646 |
| GeneOntologyBiologicalProcess | oogenesis | 1.18e-03 | 156 | 61 | 4 | GO:0048477 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 1.19e-03 | 269 | 61 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | neuron projection development | RELN ARID1B PTPRD MYO5B PTPRO USP9X ROR2 SEC24B GATA3 TMEM30A ATP1B2 | 1.23e-03 | 1285 | 61 | 11 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 1.26e-03 | 1090 | 61 | 10 | GO:0022603 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 1.26e-03 | 407 | 61 | 6 | GO:0045787 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.27e-03 | 72 | 61 | 3 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 1.30e-03 | 1095 | 61 | 10 | GO:0060284 | |
| GeneOntologyBiologicalProcess | mammary gland development | 1.35e-03 | 162 | 61 | 4 | GO:0030879 | |
| GeneOntologyBiologicalProcess | odontoblast differentiation | 1.42e-03 | 19 | 61 | 2 | GO:0071895 | |
| GeneOntologyBiologicalProcess | organelle fission | 1.44e-03 | 571 | 61 | 7 | GO:0048285 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.50e-03 | 421 | 61 | 6 | GO:0060562 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 1.54e-03 | 77 | 61 | 3 | GO:0060425 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.58e-03 | 750 | 61 | 8 | GO:0048729 | |
| GeneOntologyBiologicalProcess | regulation of mammary gland epithelial cell proliferation | 1.74e-03 | 21 | 61 | 2 | GO:0033599 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 1.78e-03 | 81 | 61 | 3 | GO:0060997 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 1.91e-03 | 83 | 61 | 3 | GO:1902893 | |
| GeneOntologyBiologicalProcess | mammary gland alveolus development | 1.91e-03 | 22 | 61 | 2 | GO:0060749 | |
| GeneOntologyBiologicalProcess | mammary gland lobule development | 1.91e-03 | 22 | 61 | 2 | GO:0061377 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.94e-03 | 443 | 61 | 6 | GO:1903311 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 1.98e-03 | 84 | 61 | 3 | GO:0061180 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 1.98e-03 | 84 | 61 | 3 | GO:0061614 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 2.13e-03 | 307 | 61 | 5 | GO:0090068 | |
| GeneOntologyBiologicalProcess | cell junction organization | 2.14e-03 | 974 | 61 | 9 | GO:0034330 | |
| MousePheno | abnormal ovarian follicle number | 1.76e-05 | 203 | 57 | 7 | MP:0008871 | |
| MousePheno | abnormal sternebra number | 1.79e-05 | 13 | 57 | 3 | MP:0012282 | |
| MousePheno | female infertility | 3.80e-05 | 410 | 57 | 9 | MP:0001926 | |
| MousePheno | absent ovarian follicles | 5.38e-05 | 51 | 57 | 4 | MP:0002777 | |
| MousePheno | abnormal ovarian follicle morphology | 5.84e-05 | 245 | 57 | 7 | MP:0001131 | |
| MousePheno | abnormal cervical vertebrae morphology | 1.26e-04 | 120 | 57 | 5 | MP:0003048 | |
| MousePheno | abnormal female reproductive system physiology | 1.75e-04 | 876 | 57 | 12 | MP:0003699 | |
| Domain | Homeobox_Antennapedia_CS | 4.44e-05 | 21 | 62 | 3 | IPR001827 | |
| Domain | ANTENNAPEDIA | 6.71e-05 | 24 | 62 | 3 | PS00032 | |
| Domain | Homeobox_metazoa | 2.27e-04 | 90 | 62 | 4 | IPR020479 | |
| Domain | PTPc | 2.30e-04 | 36 | 62 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.92e-04 | 39 | 62 | 3 | PS50055 | |
| Domain | PTPase_domain | 3.39e-04 | 41 | 62 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 3.39e-04 | 41 | 62 | 3 | PF00102 | |
| Domain | RRM_1 | 6.31e-04 | 208 | 62 | 5 | PF00076 | |
| Domain | Homeobox_antennapedia | 7.00e-04 | 12 | 62 | 2 | IPR017995 | |
| Domain | RRM | 7.64e-04 | 217 | 62 | 5 | SM00360 | |
| Domain | RRM_dom | 9.35e-04 | 227 | 62 | 5 | IPR000504 | |
| Domain | RRM | 9.91e-04 | 230 | 62 | 5 | PS50102 | |
| Domain | PTPc_motif | 9.92e-04 | 59 | 62 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 9.92e-04 | 59 | 62 | 3 | IPR003595 | |
| Domain | HOMEOBOX_1 | 1.11e-03 | 236 | 62 | 5 | PS00027 | |
| Domain | HOX | 1.13e-03 | 237 | 62 | 5 | SM00389 | |
| Domain | HOMEOBOX_2 | 1.18e-03 | 239 | 62 | 5 | PS50071 | |
| Domain | Homeobox_dom | 1.18e-03 | 239 | 62 | 5 | IPR001356 | |
| Domain | - | 1.29e-03 | 244 | 62 | 5 | 3.30.70.330 | |
| Domain | Kringle | 1.43e-03 | 17 | 62 | 2 | IPR000001 | |
| Domain | Kringle_CS | 1.43e-03 | 17 | 62 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 1.43e-03 | 17 | 62 | 2 | PS50070 | |
| Domain | Kringle | 1.43e-03 | 17 | 62 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 1.43e-03 | 17 | 62 | 2 | PS00021 | |
| Domain | KR | 1.43e-03 | 17 | 62 | 2 | SM00130 | |
| Domain | Nucleotide-bd_a/b_plait | 1.65e-03 | 258 | 62 | 5 | IPR012677 | |
| Domain | Tyr_Pase_AS | 1.84e-03 | 73 | 62 | 3 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_1 | 2.93e-03 | 86 | 62 | 3 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 3.03e-03 | 87 | 62 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 3.03e-03 | 87 | 62 | 3 | IPR000387 | |
| Domain | Homeobox_CS | 3.39e-03 | 186 | 62 | 4 | IPR017970 | |
| Domain | - | 3.55e-03 | 92 | 62 | 3 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 4.36e-03 | 99 | 62 | 3 | IPR029021 | |
| Domain | Homeodomain-like | 4.87e-03 | 332 | 62 | 5 | IPR009057 | |
| Domain | Kringle-like | 5.04e-03 | 32 | 62 | 2 | IPR013806 | |
| Pathway | WP_OVARIAN_INFERTILITY | 1.85e-07 | 35 | 53 | 5 | MM15948 | |
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 7670487 | ||
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 11694340 | ||
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 9321470 | ||
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 9.77e-12 | 4 | 63 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 9.77e-12 | 4 | 63 | 4 | 11688365 | |
| Pubmed | 9.77e-12 | 4 | 63 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 9.77e-12 | 4 | 63 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 9.77e-12 | 4 | 63 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 9.77e-12 | 4 | 63 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 9.77e-12 | 4 | 63 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 9.77e-12 | 4 | 63 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 9.77e-12 | 4 | 63 | 4 | 16963411 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 23579190 | ||
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 4.88e-11 | 5 | 63 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 4.88e-11 | 5 | 63 | 4 | 17416365 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 22293198 | ||
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 4.88e-11 | 5 | 63 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 4.88e-11 | 5 | 63 | 4 | 8968756 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 4.88e-11 | 5 | 63 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 4.88e-11 | 5 | 63 | 4 | 26411291 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 4.88e-11 | 5 | 63 | 4 | 14648873 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 8896558 | ||
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 4.88e-11 | 5 | 63 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 4.88e-11 | 5 | 63 | 4 | 9288969 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 4.88e-11 | 5 | 63 | 4 | 10903443 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 4.88e-11 | 5 | 63 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 4.88e-11 | 5 | 63 | 4 | 8845845 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 4.88e-11 | 5 | 63 | 4 | 19783541 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 17761180 | ||
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 4.88e-11 | 5 | 63 | 4 | 12200456 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 11514340 | ||
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 4.88e-11 | 5 | 63 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 4.88e-11 | 5 | 63 | 4 | 23223451 | |
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 11804965 | ||
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 21270429 | ||
| Pubmed | 4.88e-11 | 5 | 63 | 4 | 8661148 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 1.46e-10 | 6 | 63 | 4 | 18452650 | |
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 1.46e-10 | 6 | 63 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.46e-10 | 6 | 63 | 4 | 31355046 | |
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 20157580 | ||
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.46e-10 | 6 | 63 | 4 | 26077710 | |
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 17526644 | ||
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 1.46e-10 | 6 | 63 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.46e-10 | 6 | 63 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 1.46e-10 | 6 | 63 | 4 | 23417416 | |
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 32170089 | ||
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 16278232 | ||
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.46e-10 | 6 | 63 | 4 | 16001084 | |
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 1.46e-10 | 6 | 63 | 4 | 1869307 | |
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 11390979 | ||
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 27632217 | ||
| Pubmed | 2.52e-10 | 20 | 63 | 5 | 22623674 | ||
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 15081113 | ||
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 22699423 | ||
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 3.41e-10 | 7 | 63 | 4 | 16946704 | |
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 10857750 | ||
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 3.41e-10 | 7 | 63 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 3.41e-10 | 7 | 63 | 4 | 26826184 | |
| Pubmed | 4.26e-10 | 22 | 63 | 5 | 23364048 | ||
| Pubmed | CASC3 FASN PTPN14 NFE2L1 USP9X EIF4G1 TMEM30A ZNF217 GRINA SS18 | 4.48e-10 | 332 | 63 | 10 | 37433992 | |
| Pubmed | Three-dimensional molecular architecture of mouse organogenesis. | 6.36e-10 | 100 | 63 | 7 | 37524711 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 6.80e-10 | 8 | 63 | 4 | 23204224 | |
| Pubmed | 6.80e-10 | 8 | 63 | 4 | 29883445 | ||
| Pubmed | 6.80e-10 | 8 | 63 | 4 | 10823932 | ||
| Pubmed | 6.80e-10 | 8 | 63 | 4 | 11869379 | ||
| Pubmed | 6.80e-10 | 8 | 63 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 6.80e-10 | 8 | 63 | 4 | 32339196 | |
| Pubmed | 6.80e-10 | 8 | 63 | 4 | 33749946 | ||
| Pubmed | 6.80e-10 | 8 | 63 | 4 | 22621333 | ||
| Pubmed | 6.80e-10 | 8 | 63 | 4 | 32686646 | ||
| Pubmed | Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8. | 8.57e-10 | 25 | 63 | 5 | 16690745 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.22e-09 | 9 | 63 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.22e-09 | 9 | 63 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.22e-09 | 9 | 63 | 4 | 19695304 | |
| Pubmed | 1.22e-09 | 9 | 63 | 4 | 28235998 | ||
| Pubmed | 1.22e-09 | 9 | 63 | 4 | 20159962 | ||
| Pubmed | Gene knockouts that cause female infertility: search for novel contraceptive targets. | 1.58e-09 | 28 | 63 | 5 | 15970507 | |
| Pubmed | 2.04e-09 | 10 | 63 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 2.04e-09 | 10 | 63 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 2.04e-09 | 10 | 63 | 4 | 38433229 | |
| Pubmed | 2.04e-09 | 10 | 63 | 4 | 23810942 | ||
| Pubmed | 2.04e-09 | 10 | 63 | 4 | 12837688 | ||
| Interaction | PBX1 interactions | 8.44e-09 | 85 | 63 | 7 | int:PBX1 | |
| Interaction | MEX3A interactions | CASC3 FASN PTPN14 NFE2L1 USP9X EIF4G1 TMEM30A R3HDM2 ZNF217 GRINA SS18 | 2.64e-08 | 384 | 63 | 11 | int:MEX3A |
| Interaction | TDRD3 interactions | 4.34e-06 | 212 | 63 | 7 | int:TDRD3 | |
| Interaction | TRIM33 interactions | 1.09e-05 | 453 | 63 | 9 | int:TRIM33 | |
| Interaction | FLI1 interactions | 4.22e-05 | 62 | 63 | 4 | int:FLI1 | |
| Interaction | BICRA interactions | 5.73e-05 | 67 | 63 | 4 | int:BICRA | |
| Interaction | SMG7 interactions | 6.03e-05 | 319 | 63 | 7 | int:SMG7 | |
| Interaction | FAM168A interactions | 8.19e-05 | 142 | 63 | 5 | int:FAM168A | |
| Interaction | PUM2 interactions | 8.75e-05 | 144 | 63 | 5 | int:PUM2 | |
| Interaction | LGALS3 interactions | 9.00e-05 | 340 | 63 | 7 | int:LGALS3 | |
| Interaction | DAZL interactions | 9.04e-05 | 145 | 63 | 5 | int:DAZL | |
| Interaction | C19orf53 interactions | 1.00e-04 | 29 | 63 | 3 | int:C19orf53 | |
| Interaction | CHTF8 interactions | 1.00e-04 | 29 | 63 | 3 | int:CHTF8 | |
| Interaction | UBP1 interactions | 1.09e-04 | 79 | 63 | 4 | int:UBP1 | |
| Cytoband | 17q21.3 | 1.30e-06 | 16 | 62 | 3 | 17q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 3.56e-06 | 473 | 62 | 7 | chr17q21 | |
| Cytoband | Yq11.223 | 8.04e-06 | 93 | 62 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 8.46e-04 | 311 | 62 | 4 | chrYq11 | |
| Cytoband | 6q25.1 | 1.22e-03 | 38 | 62 | 2 | 6q25.1 | |
| Cytoband | 17q21 | 3.32e-03 | 63 | 62 | 2 | 17q21 | |
| GeneFamily | RNA binding motif containing | 1.45e-04 | 213 | 43 | 5 | 725 | |
| GeneFamily | HOXL subclass homeoboxes | 2.55e-04 | 52 | 43 | 3 | 518 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.13e-03 | 21 | 43 | 2 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 6.48e-03 | 160 | 43 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.59e-03 | 161 | 43 | 3 | 593 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.38e-08 | 12 | 62 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 1.38e-08 | 12 | 62 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 2.43e-07 | 23 | 62 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 8.51e-07 | 31 | 62 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.10e-06 | 33 | 62 | 4 | MM701 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INHIBITORY_NEURON_PROGENITORS | 4.41e-05 | 29 | 62 | 3 | MM3651 | |
| Coexpression | MADAN_DPPA4_TARGETS | 5.21e-05 | 86 | 62 | 4 | MM1312 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 7.08e-05 | 93 | 62 | 4 | MM1185 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP | 8.79e-05 | 190 | 62 | 5 | M4216 | |
| Coexpression | GSE3982_MAST_CELL_VS_NEUTROPHIL_UP | 1.09e-04 | 199 | 62 | 5 | M5432 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_DN | 1.12e-04 | 200 | 62 | 5 | M4788 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_UP | 1.12e-04 | 200 | 62 | 5 | M5461 | |
| Coexpression | NEBEN_AML_WITH_FLT3_OR_NRAS_UP | 1.53e-04 | 8 | 62 | 2 | M16304 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | 1.66e-06 | 498 | 62 | 10 | PCBC_ratio_EB_vs_SC_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 3.16e-06 | 416 | 62 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | HOXA5 HOXB5 RELN HOXB8 PTPN14 GTF2I PTPRO USP9X SEC24B SECISBP2 PATJ | 1.68e-05 | 795 | 62 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | HOXA5 HOXB5 RELN HOXB8 TENM4 MYO5B PTPRO USP9X XYLB CUBN PATJ | 2.02e-05 | 811 | 62 | 11 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | HOXB5 HOXB8 MYO5B PTPRO USP9X GATA3 SECISBP2 EPS8L1 PATJ FOXA1 | 8.58e-05 | 786 | 62 | 10 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 1.19e-04 | 818 | 62 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 1.24e-04 | 166 | 62 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.24e-04 | 166 | 62 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 1.56e-04 | 398 | 62 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.59e-04 | 175 | 62 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05 | 1.78e-04 | 284 | 62 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_100 | 2.09e-04 | 100 | 62 | 4 | PCBC_ratio_EB_vs_SC_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.22e-04 | 188 | 62 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 2.80e-04 | 740 | 62 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | HOXB5 HOXB8 TENM4 PTPRO ROR2 GATA3 FGA ADAMTS18 TSHZ1 DLX3 CDON | 2.92e-04 | 1094 | 62 | 11 | ratio_EB_vs_SC_2500_K3 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 151 | 62 | 5 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.94e-06 | 178 | 62 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 5.08e-06 | 179 | 62 | 5 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-06 | 186 | 62 | 5 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 6.28e-06 | 187 | 62 | 5 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 6.61e-06 | 189 | 62 | 5 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.96e-06 | 191 | 62 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.96e-06 | 191 | 62 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | (05)_Secretory-(1)_GFP|(05)_Secretory / shred by cell type by condition | 1.16e-05 | 100 | 62 | 4 | 838340a2b7c76f603e0ef2fe4fd170bd0dbce685 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-05 | 148 | 62 | 4 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 56 | 62 | 3 | cc072782b296e75e1bb11e62d280ca199b73481e | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 56 | 62 | 3 | 0c137f6263626df9837e5c00fa6ba6201bfebf52 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ttn_(Neuron.Gad1Gad2.Ttn)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 56 | 62 | 3 | 435fdc82c2c078e5f37a60de36ce80ca0c3aade8 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3-Excitatory_Neuron.Slc17a7-Slc17a6.Nxph3-Cbln2-Htr2c_(Deep_layer_subiculum)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.91e-05 | 57 | 62 | 3 | 35494ca30bdafb4c175d74f0b4892098411784b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.97e-05 | 158 | 62 | 4 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 174 | 62 | 4 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 174 | 62 | 4 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 174 | 62 | 4 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 179 | 62 | 4 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 180 | 62 | 4 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 180 | 62 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 180 | 62 | 4 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 180 | 62 | 4 | 6327c938a4f99df9fee714e44f15ea4a4a63ae15 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 181 | 62 | 4 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 181 | 62 | 4 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 181 | 62 | 4 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 181 | 62 | 4 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 182 | 62 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 183 | 62 | 4 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 184 | 62 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 184 | 62 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 184 | 62 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 184 | 62 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 185 | 62 | 4 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 1.31e-04 | 186 | 62 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 186 | 62 | 4 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 186 | 62 | 4 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 186 | 62 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.34e-04 | 187 | 62 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.34e-04 | 187 | 62 | 4 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 188 | 62 | 4 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | Endothelial-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-04 | 188 | 62 | 4 | ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-04 | 188 | 62 | 4 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 188 | 62 | 4 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 189 | 62 | 4 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 189 | 62 | 4 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 191 | 62 | 4 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.48e-04 | 192 | 62 | 4 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | facs-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 192 | 62 | 4 | cca2d0fedfbd946c54d6f4fc45887117c8dae58a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 62 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 194 | 62 | 4 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 194 | 62 | 4 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-04 | 195 | 62 | 4 | 0be50d5bd0bef2240f7ace8056ce22a6ca2961b9 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.60e-04 | 196 | 62 | 4 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.60e-04 | 196 | 62 | 4 | 028a06ed92f1c058dcbeacd335625bf529e87a7b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-04 | 196 | 62 | 4 | b246e482f012dd9782b49c2a953acedfa3c1139d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-04 | 196 | 62 | 4 | 808c0a7d1889a8f3508ed9790c6dc7ec16bbc840 | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.60e-04 | 196 | 62 | 4 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 197 | 62 | 4 | 495bfdb40b640591fbbaaa99f419bb6468cef405 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.63e-04 | 197 | 62 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 197 | 62 | 4 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 197 | 62 | 4 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.63e-04 | 197 | 62 | 4 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 198 | 62 | 4 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 198 | 62 | 4 | c506334d81af672ef9ddc8c4fd2a790bdb58e63e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 198 | 62 | 4 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-04 | 199 | 62 | 4 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-04 | 199 | 62 | 4 | 5a1557fe35aa48080d4967e8724bf27f9585a5fb | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-04 | 199 | 62 | 4 | 0a657475b92aa3a713da62da364525249fdc3886 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.69e-04 | 199 | 62 | 4 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-04 | 199 | 62 | 4 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.69e-04 | 199 | 62 | 4 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-04 | 199 | 62 | 4 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 1.73e-04 | 200 | 62 | 4 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-04 | 200 | 62 | 4 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.73e-04 | 200 | 62 | 4 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-04 | 200 | 62 | 4 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 1.73e-04 | 200 | 62 | 4 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| Computational | Developmental processes. | 5.22e-05 | 333 | 44 | 8 | MODULE_220 | |
| Drug | 3-bromo-7-nitroindazole | 5.81e-10 | 36 | 62 | 6 | CID000001649 | |
| Drug | boron trichloride | 7.44e-10 | 6 | 62 | 4 | CID000025135 | |
| Drug | p11-13 | 5.53e-08 | 75 | 62 | 6 | CID000015759 | |
| Drug | desmethylazelastine | 8.85e-08 | 16 | 62 | 4 | CID000162558 | |
| Drug | 2-chlorodideoxyadenosine | 1.13e-07 | 43 | 62 | 5 | CID000072194 | |
| Drug | dazmegrel | 1.87e-07 | 19 | 62 | 4 | CID000053555 | |
| Drug | YM 026 | 1.87e-07 | 19 | 62 | 4 | CID000004443 | |
| Drug | AZFd | 4.25e-07 | 23 | 62 | 4 | CID000196489 | |
| Drug | dansylaziridine | 4.25e-07 | 23 | 62 | 4 | CID000104008 | |
| Drug | azafagomine | 4.77e-07 | 57 | 62 | 5 | CID011957435 | |
| Drug | kt S | 9.99e-07 | 66 | 62 | 5 | CID006399216 | |
| Drug | d-gluconhydroximo-1,5-lactam | 1.48e-06 | 31 | 62 | 4 | CID000003479 | |
| Drug | Vistar | 2.75e-06 | 36 | 62 | 4 | CID000040896 | |
| Drug | molybdenum disulfide | 5.68e-06 | 43 | 62 | 4 | CID000014823 | |
| Drug | propham | 6.24e-06 | 44 | 62 | 4 | CID000024685 | |
| Drug | ridogrel | 1.22e-05 | 52 | 62 | 4 | CID005362391 | |
| Drug | neocarzinostatin chromophore | 1.31e-05 | 288 | 62 | 7 | CID000447545 | |
| Drug | carbonyl sulfide | 1.62e-05 | 116 | 62 | 5 | CID000010039 | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; PC3; HT_HG-U133A | 1.69e-05 | 199 | 62 | 6 | 6660_UP | |
| Drug | TXB2 (thromboxane B2 | 1.76e-05 | 118 | 62 | 5 | CID000005461 | |
| Drug | NSC56408 | 2.47e-05 | 62 | 62 | 4 | CID000005604 | |
| Drug | NSC4322 | 3.77e-05 | 69 | 62 | 4 | CID000220862 | |
| Drug | retrothiorphan | 4.78e-05 | 26 | 62 | 3 | CID000133842 | |
| Drug | azelastine | 4.97e-05 | 74 | 62 | 4 | CID000002267 | |
| Drug | Norethindrone | 5.37e-05 | 27 | 62 | 3 | ctd:D009640 | |
| Drug | 1pxm | 6.11e-05 | 78 | 62 | 4 | CID000447959 | |
| Drug | R1128C | 7.26e-05 | 5 | 62 | 2 | CID000195787 | |
| Drug | Norethynodrel | 7.26e-05 | 5 | 62 | 2 | ctd:D009641 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.18e-04 | 176 | 62 | 5 | 7499_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.21e-04 | 177 | 62 | 5 | 1069_DN | |
| Drug | BW755C | 1.21e-04 | 93 | 62 | 4 | CID000047795 | |
| Drug | bipy | 1.43e-04 | 97 | 62 | 4 | CID000001474 | |
| Drug | bexarotene | 1.81e-04 | 437 | 62 | 7 | ctd:C095105 | |
| Drug | STOCK1N-35215; Up 200; 10uM; MCF7; HT_HG-U133A | 1.82e-04 | 193 | 62 | 5 | 6422_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.86e-04 | 194 | 62 | 5 | 6651_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 194 | 62 | 5 | 4990_DN | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | 1.91e-04 | 195 | 62 | 5 | 1318_UP | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.91e-04 | 195 | 62 | 5 | 3201_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.91e-04 | 195 | 62 | 5 | 6654_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 7357_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 3639_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 6389_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 3390_UP | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 3692_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 4477_DN | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 4540_UP | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 4717_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 3119_UP | |
| Drug | nitrefazole | 2.02e-04 | 8 | 62 | 2 | CID000071900 | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 62 | 5 | 6016_DN | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 62 | 5 | 7416_DN | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 62 | 5 | 7442_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 62 | 5 | 3609_DN | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; PC3; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 5783_UP | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 6188_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 6153_UP | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 6295_UP | |
| Drug | Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 6357_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 3675_UP | |
| Disease | Male sterility due to Y-chromosome deletions | 1.15e-09 | 8 | 61 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.15e-09 | 8 | 61 | 4 | C1507149 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.58e-06 | 41 | 61 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.58e-06 | 41 | 61 | 4 | C0858252 | |
| Disease | Neuroblastoma | 2.76e-06 | 47 | 61 | 4 | C0027819 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 4.62e-06 | 16 | 61 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 4.62e-06 | 16 | 61 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 4.62e-06 | 16 | 61 | 3 | cv:C1839071 | |
| Disease | comparative body size at age 10, self-reported | 2.30e-04 | 420 | 61 | 6 | EFO_0009819 | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 3.76e-04 | 14 | 61 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | Proteinuria | 4.34e-04 | 15 | 61 | 2 | HP_0000093 | |
| Disease | ankle brachial index | 4.95e-04 | 16 | 61 | 2 | EFO_0003912 | |
| Disease | androstenedione measurement, estrone measurement | 6.30e-04 | 18 | 61 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | Autism Spectrum Disorders | 7.36e-04 | 85 | 61 | 3 | C1510586 | |
| Disease | exercise test | 7.80e-04 | 20 | 61 | 2 | EFO_0004328 | |
| Disease | Breast Carcinoma | 8.49e-04 | 538 | 61 | 6 | C0678222 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 8.61e-04 | 21 | 61 | 2 | EFO_0022262 | |
| Disease | vital capacity | 9.40e-04 | 1236 | 61 | 9 | EFO_0004312 | |
| Disease | Hodgkin Disease | 9.46e-04 | 22 | 61 | 2 | C0019829 | |
| Disease | Squamous cell carcinoma of esophagus | 1.02e-03 | 95 | 61 | 3 | C0279626 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.02e-03 | 95 | 61 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | triglyceride measurement, alcohol drinking | 1.14e-03 | 99 | 61 | 3 | EFO_0004329, EFO_0004530 | |
| Disease | breast carcinoma | 1.15e-03 | 1019 | 61 | 8 | EFO_0000305 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.21e-03 | 101 | 61 | 3 | EFO_0004530, EFO_0007878 | |
| Disease | bone density | 1.25e-03 | 388 | 61 | 5 | EFO_0003923 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.39e-03 | 106 | 61 | 3 | EFO_0008317, EFO_0008596 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 1.43e-03 | 107 | 61 | 3 | EFO_0004614, EFO_0004615 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.51e-03 | 109 | 61 | 3 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | susceptibility to rheumatic fever measurement | 1.53e-03 | 28 | 61 | 2 | EFO_0008416 | |
| Disease | Pigmented Basal Cell Carcinoma | 1.53e-03 | 28 | 61 | 2 | C1368275 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.55e-03 | 110 | 61 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.55e-03 | 110 | 61 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.55e-03 | 110 | 61 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.59e-03 | 111 | 61 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | Malignant neoplasm of breast | 1.60e-03 | 1074 | 61 | 8 | C0006142 | |
| Disease | Carcinoma, Basal Cell | 1.65e-03 | 29 | 61 | 2 | C4721806 | |
| Disease | aortic measurement | 1.82e-03 | 251 | 61 | 4 | EFO_0020865 | |
| Disease | Hirschsprung Disease | 1.88e-03 | 31 | 61 | 2 | C0019569 | |
| Disease | sexual dimorphism measurement | 1.92e-03 | 1106 | 61 | 8 | EFO_0021796 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.04e-03 | 121 | 61 | 3 | EFO_0008595, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYDTSGQRYSPYPQH | 81 | Q5U5X8 | |
| GQRYSPYPQHTAGYQ | 86 | Q5U5X8 | |
| SAYGTQPAYPAYGQQ | 116 | Q01844 | |
| PSLGYGQSNYSYPQV | 161 | Q01844 | |
| FQNSDNPYYYPRTPG | 501 | Q86US8 | |
| NNYNVSPVELPFGGY | 446 | P49189 | |
| RPYIEYPSYNEQNGT | 441 | Q6UX41 | |
| QYGPQGNYSRPPAYS | 916 | Q8NFD5 | |
| YSGPDRRPIQGQYPY | 1481 | Q8NFD5 | |
| QGVGESEPNPYFYQN | 1186 | O60306 | |
| QVTTGYQLPVYNYQP | 201 | Q13117 | |
| QVTTGYQLPVYNYQP | 201 | Q9NR90 | |
| PQHDYYSGQPYGQTV | 46 | O60479 | |
| IQRYRGYPGSGRNYP | 211 | Q8TE60 | |
| RPYSPSQYALQYAGD | 731 | Q14494 | |
| IQVSYYPPGQYPNSN | 516 | Q9Y2K5 | |
| RPPRNGYGVYVYPNS | 21 | Q5T089 | |
| GNYQEEGPPSYYDNQ | 131 | Q7Z429 | |
| PGYGVQYDYLDPRQI | 401 | Q9Y2Z2 | |
| PGRYYEQPDNGVLNY | 131 | P14415 | |
| YYAAVPSARNVPYGN | 396 | Q10471 | |
| QQVPYYLENEPSGYT | 126 | P03372 | |
| GRYPNGPDYQLHNYG | 11 | P20719 | |
| ASVTYPRGYPYNGTN | 631 | Q9UL01 | |
| PRGYPYNGTNYVNVT | 636 | Q9UL01 | |
| YPYNNLYLERGGDPS | 161 | O95169 | |
| IAGNPTYYVPGQEYH | 61 | P78509 | |
| NYIPGYNSPQEYIAT | 996 | Q16827 | |
| GRYPNGPDYQLLNYG | 11 | P09067 | |
| DPGNFYGYDPLQRQS | 81 | P17481 | |
| EPAYYQGVYSRPVLN | 456 | P55317 | |
| QTYGILESIGYPNPY | 1286 | O60494 | |
| PPYYGNSVRATVQRY | 61 | P23771 | |
| AELQYRPPLESQYGY | 216 | Q9YNA8 | |
| AELQYQPPPESQYGY | 216 | P62684 | |
| QRQAPGPARDYSQYY | 121 | Q04695 | |
| APSQVYGGVTYYNPA | 656 | O15234 | |
| QVTTGYQLPVYNYQP | 531 | Q9NQZ3 | |
| NTPIQGFYIYYRPTD | 856 | Q4KMG0 | |
| YYPNGGLTRNYCRNP | 1206 | P08519 | |
| LPAGRYSLNVTYNYP | 286 | Q9NV96 | |
| YPASQGAYYIPGQGR | 96 | Q04637 | |
| NLNGIYYPGGSYDPR | 816 | P02671 | |
| QVTTGYQLPVYNYQP | 366 | Q86SG3 | |
| AGQEGYVPYNILTPY | 521 | Q8TE68 | |
| PDYYQYNIQAGPSET | 246 | P78347 | |
| VQPEGPYRVAGYSYG | 2296 | P49327 | |
| YGYPTLQPGYQNATA | 461 | O95487 | |
| PVYSGFQQYPQQYPG | 486 | O95487 | |
| YYYSVRIFPGQEPAN | 1426 | Q92736 | |
| PEEPNGQIQGYRVYY | 441 | P23468 | |
| LERRPYTGNPQYTYN | 2426 | Q93008 | |
| YTVPYGPQGVYSNKL | 496 | Q15678 | |
| IRYLSYPYGNPQSAG | 656 | Q6AI14 | |
| VPGSQYLYNQPSCYR | 106 | Q96T21 | |
| QLYVPVNGYQPVPAY | 816 | Q01974 | |
| YSQEAQPYGYCPENV | 931 | Q8NI35 | |
| QQPSYPEQGYDRPYE | 301 | Q15532 | |
| GAISSYYVQRYGFPP | 256 | O75191 | |
| SVGYYRNIYQPPEGN | 1971 | Q6N022 | |
| GGYRNQLYSRPGYEN | 91 | Q96JE7 | |
| YGIGTYREINPAPYT | 381 | Q93050 | |
| GRTENQPEAPYYYVN | 411 | Q5GH77 | |
| QPGANYRRGYDLPKY | 931 | O75362 | |
| AYSAYNPVSIPGQRY | 176 | Q2M2D7 | |
| ILQSYPDNSYQQPYG | 496 | Q05996 | |
| PDNSYQQPYGENEYP | 501 | Q05996 | |
| ANPYVTPNNRYGYQN | 386 | Q6ZSZ6 | |
| PYLVAANPVNYGRPY | 146 | Q9UJK0 | |
| NPYEQLPIYGQDVIY | 111 | Q9ULV0 |